+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis



Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis



Rheumatology 53(2): 307-312



The objectives of this study were to assess 27-joint Juvenile Arthritis Disease Activity Score (JADAS-27) responsiveness, JADAS-27 changes corresponding to clinically important differences and cut-off scores for low and high disease activity in a large prospective JIA cohort. JADAS-27 responsiveness, using effect size and standardized response mean (SRM), and changes in the JADAS-27 corresponding to clinically important differences were determined for clinical improvement (ACRpedi30) and worsening (flare). To assess whether various degrees of change in the JADAS-27 could be used to demonstrate improvement or worsening in individual patients, diagnostic parameters were computed for cut-off score changes. Finally, cut-off scores for low and high disease activity and their diagnostic parameters were determined. In 228 patients with 529 consecutive visits, ACRpedi30 was detected in 109 and flare in 111 visits. Regarding responsiveness, the effect size was 0.93 and SRM was 1.26 for clinical improvement, while for clinical worsening the effect size was 0.65 and SRM was 0.60. Changes in the JADAS-27 corresponding to clinically important difference were -5.5 for improvement and +1.7 for worsening. Cut-off score changes in the JADAS-27 had 65-90% sensitivity and 67-86% specificity for improvement, and 31-64% sensitivity and 89-97% specificity for worsening. The JADAS-27 cut-off score for low disease activity was ≤2.7 with 76% sensitivity and 62% specificity, and the cut-off score for high disease activity was ≥6 with 77% sensitivity and 77% specificity. The JADAS-27 had moderate to good responsiveness and was changed by clinically important differences. The JADAS-27 cut-off scores differentiated between low and high disease activity. These JADAS-27 interpretations could be potentially applicable in clinical care and trials.

(PDF emailed within 0-6 h: $19.90)

Accession: 053925887

Download citation: RISBibTeXText

PMID: 24162034

DOI: 10.1093/rheumatology/ket310


Related references

Finding specific 10-joint Juvenile Arthritis Disease Activity Score (JADAS10) and clinical JADAS10 cut-off values for disease activity levels in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study. Rheumatology 55(4): 615-623, 2016

Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score. Arthritis and Rheumatism 64(7): 2366-2374, 2012

Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score. Arthritis Care and Research 66(11): 1703-1709, 2014

Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 75(3): 635-636, 2016

FRI0330Development of cut-off values for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score (JADAS):. Annals of the Rheumatic Diseases 71(Suppl 3): 425.3-426, 2013

Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score. Annals of the Rheumatic Diseases 73(7): 1380-1383, 2014

THU0237Disease Activity in Patients with Juvenile Spondyloarthropathy on anti-TNF Therapy as Measured by The Juvenile Arthritis Disease Activity Score (JADAS)-10 and The Juvenile Spondyloarthritis Disease Activity Index (JSPADA). Annals of the Rheumatic Diseases 75(Suppl 2): 273.3-274, 2016

Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 77(3): 336-342, 2017

Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 72(12): 1983-1988, 2014

Definition of improvement in juvenile idiopathic arthritis using the juvenile arthritis disease activity score. Rheumatology 53(7): 1229-1234, 2014

Comparison of the Disease Activity Score-28 and Juvenile Arthritis Disease Activity Score in the juvenile idiopathic arthritis. Revista Brasileira de Reumatologia 55(1): 31-36, 2017

Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study. Rheumatology 49(1): 116-122, 2010

Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis. Journal of Rheumatology 38(11): 2482-2487, 2012

Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis. Yonsei Medical Journal 53(5): 1045-1048, 2013

Responsiveness of clinical measures to flare of disease activity in juvenile idiopathic arthritis. Clinical and Experimental Rheumatology 23(3): 421-425, 2005